Acurx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has compl…

Biotechnology
US, Staten Island [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ACXP's Analysis
CIK: 1736243 CUSIP: 00510M104 ISIN: US00510M1045 LEI: - UEI: -
Secondary Listings
ACXP has no secondary listings inside our databases.